Cargando…

Serum calprotectin levels as markers of inflammation, insulin resistance and hyperandrogenism in women with polycystic ovary syndrome

Polycystic ovary syndrome (PCOS) is a common, complex endocrine, and metabolic disorder. Inflammation has been thought to play an important role in PCOS pathogenesis in recent years, and various inflammatory markers have been investigated; however, no definite conclusion has been reached. As a multi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hancerliogullari, Necati, Tokmak, Aytekin, Guney, Gurhan, Pekcan, Meryem Kuru, Koc, Esin Merve, Candar, Tuba, Ustün, Yaprak Engin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	4300
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794328/ https://www.ncbi.nlm.nih.gov/pubmed/36595790 http://dx.doi.org/10.1097/MD.0000000000032326

Ejemplares similares

Evaluation of Serum Human Epididymis Protein 4 Levels in Women with Polycystic Ovary Syndrome
por: Hancerliogullari, Necati, et al.
Publicado: (2019)

Inflammatory Markers in Peripheral Blood Cells Cannot Predict Intrauterine Insemination Outcome: A Retrospective Cohort Study
por: Pekcan, Meryem Kuru, et al.
Publicado: (2021)

Does mid-luteal progesterone predict pregnancy in intrauterine insemination cycles following sequential clomiphene citrate and gonadotropin treatment?
por: Çinar, Mehmet, et al.
Publicado: (2023)

Does the addition of metformin to carboplatin treatment decreases ovarian reserve damage associated with carboplatin usage?
por: Ayhan, Sevgi, et al.
Publicado: (2023)

Role of Versican and ADAMTS-1 in Polycystic Ovary Syndrome
por: Özler, Sibel, et al.
Publicado: (2017)

Relationship Between Polycystic Ovarian Morphology and Ectopic Pregnancy
por: Ozel, Sule, et al.
Publicado: (2021)

Assessment of the Relationship between Serum Vitamin D and Osteocalcin Levels with Metabolic Syndrome in Non-Osteoporotic Postmenopausal Women
por: Guney, Gurhan, et al.
Publicado: (2019)

Is gonadotropin-releasing hormone agonist usage really leading to thyroid dysfunction?
por: Yilmaz, Nafiye, et al.
Publicado: (2019)

An ovarian Leydig cell tumor of ultrasound negative in a postmenopausal woman with hirsutism and hyperandrogenism: A case report
por: Chen, Min, et al.
Publicado: (2018)

Relationship between seasons and pregnancy rates during intrauterine insemination. A historical cohort
por: Pekcan, Meryem Kuru, et al.
Publicado: (2019)

Does an increased number of cesarean sections result in greater risk for mother and baby in low-risk, late preterm and term deliveries?
por: Hancerliogullari, Necati, et al.
Publicado: (2019)

Reporting quality of polycystic ovary syndrome practice guidelines based on the RIGHT checklist
por: Li, Hongzhu, et al.
Publicado: (2020)

Tanshinone for polycystic ovary syndrome: A protocol of systematic review and meta-analysis
por: Yang, Yijiao, et al.
Publicado: (2021)

Are ABO/Rh blood groups A risk factor for polycystic ovary syndrome?
por: Dogan, Ozlem
Publicado: (2023)

Metformin and acupuncture for polycystic ovary syndrome: A protocol for a systematic review and meta-analysis
por: Gao, Yang, et al.
Publicado: (2020)

The effects of water immersion and epidural analgesia on cellular immune response, neuroendocrine, and oxidative markers
por: UZUNLAR, Özlem, et al.
Publicado: (2021)

Influence of Catheter Type and Tenaculum Use on Intrauterine Insemination Outcome
por: Gulsen Coban, Pinar, et al.
Publicado: (2020)

Adiponectin/(FBG × FIns) as a predictor of insulin sensitivity and metabolic syndrome in patients with polycystic ovary syndrome
por: Xu, Xiaohui, et al.
Publicado: (2016)

The correlation between UDP-glucuronosyltransferase polymorphisms and environmental endocrine disruptors levels in polycystic ovary syndrome patients
por: Luo, Yunyao, et al.
Publicado: (2020)

Obstetric Outcomes among Syrian Refugees: A Comparative Study at a Tertiary Care Maternity Hospital in Turkey
por: Ozel, Sule, et al.
Publicado: (2018)

Effects of inositol and alpha lipoic acid combination for polycystic ovary syndrome: A protocol for systematic review and meta-analysis
por: Lei, Wenwen, et al.
Publicado: (2020)

Comparison of thyroid fine needle aspiration biopsy and ultrasonography results
por: Keskin, Lezzan, et al.
Publicado: (2023)

Comparison of different drug for reducing testosterone levels in women with polycystic ovary syndrome: A systematic review and network meta-analysis
por: Hao, Song-Li, et al.
Publicado: (2023)

The Role of Inflammatory Hematological Markers in Predicting IVF Success
por: Ozgu-Erdinc, A Seval, et al.
Publicado: (2021)

Effects of vitamin D supplementation on serum lipid profile in women with polycystic ovary syndrome: A protocol for a systematic review and meta-analysis
por: Shi, Xiao-yan, et al.
Publicado: (2020)

Assessment of three different radioiodine doses for ablation therapy of thyroid remnants: Efficiency, complications and patient comfort
por: Soyluoglu, Selin, et al.
Publicado: (2023)

Serum Vitamin D Levels in Fertile and Infertile Women with Polycystic Ovary Syndrome
por: Kokanalı, Demet, et al.
Publicado: (2019)

Clomiphene Citrate Treatment Cycle Outcomes of Polycystic Ovary Syndrome Patients Based on Basal High Sensitive C-Reactive Protein Levels: A Cross-Sectional Study
por: Kahyaoglu, Serkan, et al.
Publicado: (2017)

The Relationship Between Hearing Thresholds and Hyperandrogenism in Polycystic Ovary Syndrome
por: Turan, Mahfuz, et al.
Publicado: (2016)

Hyperandrogenism correlates with psychological symptoms in adolescents with polycystic ovary syndrome
por: Donbaloğlu, Zeynep, et al.
Publicado: (2022)

A Prognostic Marker in Idiopathic Sudden Sensorineural Hearing Loss: Serum Calprotectin
por: Kuzucu, İhsan, et al.
Publicado: (2020)

There is No Association between Premature Ovarian Insufficiency and Levels of Fetuin-A/α2-Heremans-Schmid Glycoprotein
por: Ozgu-Erdinc, A. Seval, et al.
Publicado: (2019)

Metformin Therapy Decreases Hyperandrogenism and Ovarian Volume in Women with Polycystic Ovary Syndrome
por: Farimani Sanoee, Marzieh, et al.
Publicado: (2011)

Ovarian Aging-Like Phenotype in the Hyperandrogenism-Induced Murine Model of Polycystic Ovary
por: Rezvanfar, Mohammad Amin, et al.
Publicado: (2014)

Are Psychosocial Consequences of Obesity and Hyperandrogenism Present in Adolescent Girls with Polycystic Ovary Syndrome?
por: Zachurzok, Agnieszka, et al.
Publicado: (2018)

Telomere Length Differently Associated to Obesity and Hyperandrogenism in Women With Polycystic Ovary Syndrome
por: Velazquez, Mariela Edith, et al.
Publicado: (2021)

Is anti-Mullerian hormone a good diagnostic marker for adolescent and young adult patients with Polycystic ovary syndrome?
por: Tokmak, Aytekin, et al.
Publicado: (2015)

Identification of Differentially Expressed MicroRNAs in the Ovary of Polycystic Ovary Syndrome with Hyperandrogenism and Insulin Resistance
por: Lin, Lin, et al.
Publicado: (2015)

Effects of hyperandrogenism on metabolic abnormalities in patients with polycystic ovary syndrome: a meta-analysis
por: Yang, Rui, et al.
Publicado: (2016)

Correlation between biochemical and clinical hyperandrogenism parameter in polycystic ovary syndrome in relation to age
por: Guo, Zaixin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t6rg9il9fjskn2m4a2k79i4g9h